Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.

Identifieur interne : 000576 ( Main/Exploration ); précédent : 000575; suivant : 000577

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.

Auteurs : Grant W. Waterer [Australie, États-Unis] ; Jordi Rello [Espagne, France]

Source :

RBID : pubmed:32953385

Abstract

COVID-19 is a new infectious disease causing severe respiratory failure and death for which optimal treatment is currently unclear. Many therapies have been proven to be ineffective; however, promising findings related to corticosteroid therapy have been published. Analysis of published data including in this issue suggests that therapy with corticosteroids in the range of 6 mg of dexamethasone (or equivalent) per day likely has a positive effect in patients requiring mechanical ventilation but there remains considerable doubt in patients over the age of 70, in patients with diabetes and patients with milder disease. Clinicians must consider the individual potential risks and benefits of corticosteroid in patients with COVID-19 rather than routinely using them until more data is available.

DOI: 10.1007/s40121-020-00338-x
PubMed: 32953385
PubMed Central: PMC7492684


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.</title>
<author>
<name sortKey="Waterer, Grant W" sort="Waterer, Grant W" uniqKey="Waterer G" first="Grant W" last="Waterer">Grant W. Waterer</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Western Australia, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Western Australia, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Northwestern University, Chicago, IL USA.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Northwestern University, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centro de Investigación Biomedica en Red (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Investigación Biomedica en Red (CIBERES), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Vall d'Hebron Institute of Research (VHIR), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32953385</idno>
<idno type="pmid">32953385</idno>
<idno type="doi">10.1007/s40121-020-00338-x</idno>
<idno type="pmc">PMC7492684</idno>
<idno type="wicri:Area/Main/Corpus">000063</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000063</idno>
<idno type="wicri:Area/Main/Curation">000063</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000063</idno>
<idno type="wicri:Area/Main/Exploration">000063</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.</title>
<author>
<name sortKey="Waterer, Grant W" sort="Waterer, Grant W" uniqKey="Waterer G" first="Grant W" last="Waterer">Grant W. Waterer</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Western Australia, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Western Australia, Perth</wicri:regionArea>
<wicri:noRegion>Perth</wicri:noRegion>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Northwestern University, Chicago, IL USA.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Northwestern University, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name>
<affiliation wicri:level="3">
<nlm:affiliation>Centro de Investigación Biomedica en Red (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Centro de Investigación Biomedica en Red (CIBERES), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Vall d'Hebron Institute of Research (VHIR), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Infectious diseases and therapy</title>
<idno type="ISSN">2193-8229</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">COVID-19 is a new infectious disease causing severe respiratory failure and death for which optimal treatment is currently unclear. Many therapies have been proven to be ineffective; however, promising findings related to corticosteroid therapy have been published. Analysis of published data including in this issue suggests that therapy with corticosteroids in the range of 6 mg of dexamethasone (or equivalent) per day likely has a positive effect in patients requiring mechanical ventilation but there remains considerable doubt in patients over the age of 70, in patients with diabetes and patients with milder disease. Clinicians must consider the individual potential risks and benefits of corticosteroid in patients with COVID-19 rather than routinely using them until more data is available.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32953385</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">2193-8229</ISSN>
<JournalIssue CitedMedium="Print">
<PubDate>
<Year>2020</Year>
<Month>Sep</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Infectious diseases and therapy</Title>
<ISOAbbreviation>Infect Dis Ther</ISOAbbreviation>
</Journal>
<ArticleTitle>Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.</ArticleTitle>
<Pagination>
<MedlinePgn>1-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40121-020-00338-x</ELocationID>
<Abstract>
<AbstractText>COVID-19 is a new infectious disease causing severe respiratory failure and death for which optimal treatment is currently unclear. Many therapies have been proven to be ineffective; however, promising findings related to corticosteroid therapy have been published. Analysis of published data including in this issue suggests that therapy with corticosteroids in the range of 6 mg of dexamethasone (or equivalent) per day likely has a positive effect in patients requiring mechanical ventilation but there remains considerable doubt in patients over the age of 70, in patients with diabetes and patients with milder disease. Clinicians must consider the individual potential risks and benefits of corticosteroid in patients with COVID-19 rather than routinely using them until more data is available.</AbstractText>
<CopyrightInformation>© The Author(s) 2020.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Waterer</LastName>
<ForeName>Grant W</ForeName>
<Initials>GW</Initials>
<AffiliationInfo>
<Affiliation>University of Western Australia, Perth, Australia.</Affiliation>
<Identifier Source="GRID">grid.1012.2</Identifier>
<Identifier Source="ISNI">0000 0004 1936 7910</Identifier>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Northwestern University, Chicago, IL USA.</Affiliation>
<Identifier Source="GRID">grid.16753.36</Identifier>
<Identifier Source="ISNI">0000 0001 2299 3507</Identifier>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rello</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Centro de Investigación Biomedica en Red (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
<Identifier Source="GRID">grid.413448.e</Identifier>
<Identifier Source="ISNI">0000 0000 9314 1427</Identifier>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.</Affiliation>
<Identifier Source="GRID">grid.430994.3</Identifier>
<Identifier Source="ISNI">0000 0004 1763 0287</Identifier>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Clinical Research, CHU Nîmes, Université Montpellier-Nîmes, Nîmes, France.</Affiliation>
<Identifier Source="GRID">grid.411165.6</Identifier>
<Identifier Source="ISNI">0000 0004 0593 8241</Identifier>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>09</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>New Zealand</Country>
<MedlineTA>Infect Dis Ther</MedlineTA>
<NlmUniqueID>101634499</NlmUniqueID>
<ISSNLinking>2193-6382</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ARDS</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Covid-19</Keyword>
<Keyword MajorTopicYN="N">Pneumonia</Keyword>
<Keyword MajorTopicYN="N">Precision medicine</Keyword>
<Keyword MajorTopicYN="N">RCT</Keyword>
<Keyword MajorTopicYN="N">SARS</Keyword>
<Keyword MajorTopicYN="N">Therapy</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>08</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>13</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32953385</ArticleId>
<ArticleId IdType="doi">10.1007/s40121-020-00338-x</ArticleId>
<ArticleId IdType="pii">338</ArticleId>
<ArticleId IdType="pmc">PMC7492684</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList>
<Reference>
<Citation>BMJ. 2017 Apr 12;357:j1415</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28404617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 22;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2020 May 21;55(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32341111</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Metab. 2020 Jun 2;31(6):1068-1077.e3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32369736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2011 Feb;37(2):272-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21107529</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Dis Ther. 2020 Sep 2;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32880102</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 May 19;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32427279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Aug 12;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32785710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jul 23;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2020 Jun 1;201(11):1324-1325</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32311297</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anaesth Crit Care Pain Med. 2020 Apr 9;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32278670</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Allergy Clin Immunol. 2020 Aug;146(2):325-327</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32479759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2018 Sep;44(9):1470-1482</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30074052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Sep 15;324(11):1048-1057</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32821939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Commun Dis Intell (2018). 2020 Jul 14;44:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32664828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 11;382(24):2327-2336</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32275812</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Espagne</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
<li>Illinois</li>
<li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Madrid</li>
<li>Nîmes</li>
</settlement>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Waterer, Grant W" sort="Waterer, Grant W" uniqKey="Waterer G" first="Grant W" last="Waterer">Grant W. Waterer</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Illinois">
<name sortKey="Waterer, Grant W" sort="Waterer, Grant W" uniqKey="Waterer G" first="Grant W" last="Waterer">Grant W. Waterer</name>
</region>
</country>
<country name="Espagne">
<region name="Communauté de Madrid">
<name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name>
</region>
<name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name>
</country>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Rello, Jordi" sort="Rello, Jordi" uniqKey="Rello J" first="Jordi" last="Rello">Jordi Rello</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000576 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000576 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32953385
   |texte=   Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32953385" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021